450 filings
Page 15 of 23
8-K
hs5nc0jz00z7qru lto2
27 Feb 17
Other Events
12:00am
8-K
h69bqowk s6cnwjmfg
6 Jan 17
Other Events
12:00am
8-K
qam6wl7y er3b
16 Dec 16
Other Events
12:00am
424B4
n79 gjixj60y11lagc
14 Dec 16
Prospectus supplement with pricing info
12:00am
EFFECT
voh621jmeaa
13 Dec 16
Notice of effectiveness
12:00am
CORRESP
8c4kqng1g78x3p
12 Dec 16
Correspondence with SEC
12:00am
CORRESP
ufe65 x5v8
12 Dec 16
Correspondence with SEC
12:00am
8-K
158mo3 86d
8 Dec 16
Entry into a Material Definitive Agreement
12:00am
UPLOAD
qg08k39ajii1l 3a
7 Dec 16
Letter from SEC
12:00am
8-K
875q1
30 Nov 16
Other Events
12:00am
8-K
whgw9 nmsk
28 Nov 16
Recro Pharma Reports Positive Top-Line Results from Pivotal Phase III Clinical Trial of IV Meloxicam
12:00am
8-K
atgde0glc x5l
15 Nov 16
Other Events
12:00am
8-K
31i9aa r28odc
10 Nov 16
Recro Pharma Reports Third Quarter 2016 Financial Results
12:00am
8-K
5i9wvebse
12 Sep 16
Other Events
12:00am
8-K
cpyisja im
8 Sep 16
Recro Pharma Presents Clinical Data at PAINWeek 2016
12:00am
8-K
uepmoslon jot
17 Aug 16
Recro Pharma Announces Proposed Public Offering of Common Stock
12:00am